查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621348

蝦病診斷市場：按套件、疾病和最終用戶分類 - 全球預測 2025-2030

Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年蝦病診斷市值為4.4318億美元，預計2024年將達到4.781億美元，複合年成長率為7.92%，預計到2030年將達到7.5583億美元。

調查方法範圍涵蓋各種旨在識別蝦類疾病的診斷工具和技術，這對於維持蝦類健康和永續水產養殖至關重要。全球對蝦的需求不斷成長以及水產養殖業的相應成長推動了對此類診斷的需求，水產養殖業的疾病爆發導致重大經濟損失和供應鏈中斷。蝦子的疾病診斷應用包括白斑症候群、傳染性皮下脂肪變性和造血壞死病毒等疾病的早期檢測和預防。最終用途主要包括養魚場、水生獸醫院和診斷實驗室。主要市場成長要素包括水產養殖業的快速成長、診斷工具的技術進步以及對永續水產養殖需求的認知不斷提高。開發具有成本效益、反應靈敏的診斷工具是有機會的，這些工具在現場條件下很容易獲得。另一種可能性是將人工智慧和機器學習等數位技術整合到診斷中，從而實現預測分析和改進的疾病管理策略。

主要市場統計
基準年[2023] 44318萬美元
預計年份 [2024] 4.781 億美元
預測年份 [2030] 75583萬美元
複合年成長率（%） 7.92%

然而，先進診斷工具的高成本、新興市場缺乏基礎設施以及監管挑戰等限制因素可能會阻礙市場成長。該行業還面臨實現標準化診斷程序和確保結果準確可靠的挑戰。需要創新和研究的領域包括開發低成本攜帶式診斷試劑套件、改進生物感測器技術以及探索抗病基因解決方案。投資學術機構和產業參與者之間的研究夥伴關係可以帶來抗病蝦品種的突破性發現。市場競爭是溫和的，因此企業必須不斷創新才能保持競爭力。公司應專注於擴大其地理覆蓋範圍，可能瞄準水產養殖正在成長的新興市場。此外，透過強調永續和環保的解決方案，我們可以回應消費者對環保生產實踐日益成長的興趣。

市場動態：揭示快速發展的蝦病診斷市場的關鍵市場洞察

供需的動態交互作用正在改變蝦病診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大世界各地的蝦子生產和出口活動
    • 應對蝦病的公共和私人意識提升計劃和福利計劃
    • 對蝦養殖的品質監管和高效疾病檢測工具的需求
  • 市場限制因素
    • 複雜的測試程序和需要訓練的人員
  • 市場機會
    • 蝦子診斷技術和快速檢測方法的進展
    • 新投資擴大蝦類養殖活動
  • 市場挑戰
    • 蝦子病診斷中與假陽性和不準確相關的局限性

波特的五力蝦子策略工具引領疾病診斷市場

波特的五力框架是了解蝦子病診斷市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解蝦子病診斷市場的外部影響

外部宏觀環境因素在塑造蝦病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解蝦子病診斷市場的競爭狀況

對蝦病診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣蝦病診斷市場供應商的績效評估

FPNV定位矩陣是評估蝦子病診斷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃蝦病診斷市場的成功之路

對蝦病診斷市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的蝦子生產和出口不斷擴大
      • 應對蝦病的公共和私人意識活動和福利計劃
      • 高品質對蝦養殖需要法規和有效的疾病檢測工具
    • 抑制因素
      • 複雜的測試程序和需要訓練的人員
    • 機會
      • 蝦子診斷技術和快速檢測方法的進展
      • 新投資擴大蝦類養殖活動
    • 任務
      • 蝦子病診斷中與假陽性和不準確相關的局限性
  • 市場區隔分析
    • 套件：更多採用快速檢測套組來快速、輕鬆地檢測病原體
    • 疾病：白斑症病毒 (WSSV) 具有高度傳染性，需要高品質的 PCR 和組織學檢測。
    • 最終用戶：漁業中蝦病發病率的增加需要部署蝦病診斷策略
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 蝦病診斷市場試劑套件

  • 檢測基礎套件
  • 快速檢測套組

第7章蝦病診斷市場：依疾病分類

  • 早死綜合症
  • 桃拉症候群病毒
  • 白癜風症候群病毒
  • 黃頭或鰓相關病毒

第8章蝦病診斷市場：依最終用戶分類

  • 水產養殖與海洋研究所
  • 教育及研究機構
  • 釣魚

第9章 北美和南美蝦病診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區蝦病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲蝦病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 美國計劃為蝦農開發低成本白斑症測試
    • ViAqua Therapeutics 獲得基於 RNA 的水產養殖疾病管理資金
    • Aquatrek 簽署研究協議，為養魚場開發診斷服務
  • 戰略分析和建議

公司名單

  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem（M）Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corp.
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings（Pvt）Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika（Nusantics）
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.
Product Code: MRR-03023C19E52A

The Shrimp Disease Diagnostics Market was valued at USD 443.18 million in 2023, expected to reach USD 478.10 million in 2024, and is projected to grow at a CAGR of 7.92%, to USD 755.83 million by 2030.

The scope of the shrimp disease diagnostics market covers a range of diagnostic tools and methodologies designed to identify diseases in shrimp populations, vital to maintaining shrimp health and ensuring sustainable aquaculture practices. The necessity of these diagnostics arises from the increasing global demand for shrimp and the corresponding rise in aquaculture, where disease outbreaks can lead to significant economic losses and supply chain disruptions. Applications of shrimp disease diagnostics include early detection and prevention of diseases like white spot syndrome, infectious hypodermal and hematopoietic necrosis virus, among others. End-use scope primarily includes aquaculture farms, veterinary clinics specializing in aquatic creatures, and diagnostic laboratories. Key market growth factors include the burgeoning aquaculture industry, technological advancements in diagnostic tools, and increased awareness of the need for sustainable aqua farming practices. Opportunities lie in developing cost-effective, quick-response diagnostic tools that can be easily utilized in field conditions. Another potential opportunity is the integration of digital technologies such as AI and machine learning in diagnostics, allowing for predictive analytics and improved disease management strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 443.18 million
Estimated Year [2024] USD 478.10 million
Forecast Year [2030] USD 755.83 million
CAGR (%) 7.92%

However, limitations such as high costs associated with advanced diagnostic tools, lack of infrastructure in developing regions, and regulatory challenges could impede market growth. The industry also faces challenges in achieving standardized diagnostic procedures and ensuring accuracy and reliability outcomes. Areas ripe for innovation and research include developing low-cost portable diagnostic kits, improving biosensor technology, and exploring genetic solutions for disease resistance. Investing in research partnerships between academic institutions and industry players could foster breakthroughs in disease-resistant shrimp strains. The market is characterized by moderate competition, requiring players to continuously innovate to maintain a competitive edge. Companies should focus on expanding their geographic reach, possibly targeting emerging markets with growing aquaculture activities. Emphasizing sustainable and eco-friendly solutions will also cater to the increasing consumer focus on environmentally responsible production practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing shrimp production and export activities worldwide
    • Public-private awareness initiatives and welfare projects to tackle shrimp diseases
    • Regulations for quality shrimp farming and need for efficient disease detection tools
  • Market Restraints
    • Complex testing procedures and need for trained personnel
  • Market Opportunities
    • Advancements in shrimp diagnostics technologies and rapid testing methods
    • New investments in expansion of shrimp farming activities
  • Market Challenges
    • Limitations associated with false positives and inaccuracy of shrimp disease diagnostics

Porter's Five Forces: A Strategic Tool for Navigating the Shrimp Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Shrimp Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Shrimp Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Shrimp Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Shrimp Disease Diagnostics Market

A detailed market share analysis in the Shrimp Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Shrimp Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Shrimp Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Shrimp Disease Diagnostics Market

A strategic analysis of the Shrimp Disease Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Kit, market is studied across Assay Based Kit and Rapid Testing Kit.
  • Based on Disease, market is studied across Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus, and Yellow Head or Gill Associated Virus.
  • Based on End User, market is studied across Aquaculture & Marine Laboratories, Education & Research Institutes, and Fisheries.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing shrimp production and export activities worldwide
      • 5.1.1.2. Public-private awareness initiatives and welfare projects to tackle shrimp diseases
      • 5.1.1.3. Regulations for quality shrimp farming and need for efficient disease detection tools
    • 5.1.2. Restraints
      • 5.1.2.1. Complex testing procedures and need for trained personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in shrimp diagnostics technologies and rapid testing methods
      • 5.1.3.2. New investments in expansion of shrimp farming activities
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens
    • 5.2.2. Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests
    • 5.2.3. End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Shrimp Disease Diagnostics Market, by Kit

  • 6.1. Introduction
  • 6.2. Assay Based Kit
  • 6.3. Rapid Testing Kit

7. Shrimp Disease Diagnostics Market, by Disease

  • 7.1. Introduction
  • 7.2. Early Mortality Syndrome
  • 7.3. Taura Syndrome Virus
  • 7.4. White Spot Syndrome Virus
  • 7.5. Yellow Head or Gill Associated Virus

8. Shrimp Disease Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Aquaculture & Marine Laboratories
  • 8.3. Education & Research Institutes
  • 8.4. Fisheries

9. Americas Shrimp Disease Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Shrimp Disease Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. US Project to Develop Low-Cost White Spot Test for Shrimp Farmers
    • 12.3.2. ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management
    • 12.3.3. Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3 Little Fish Sdn Bhd
  • 2. Amazing Biotech
  • 3. Aquaintech Inc.
  • 4. Arachem (M) Sdn Bhd
  • 5. Bioneer Corporation
  • 6. Blue Aqua International Pte. Ltd.
  • 7. CD Genomics
  • 8. China Guangzhou BioKey Healthy Technology Co. Ltd
  • 9. DSM Austria GmbH
  • 10. Forte Biotech
  • 11. GeneReach Biotechnology Corp.
  • 12. GeneReach Biotechnology Corporation
  • 13. Genics Pty. Ltd.
  • 14. Illumina, Inc.
  • 15. Innocreate Bioscience Co., Ltd.
  • 16. Lab-Ind Resource Sdn. Bhd.
  • 17. Laboratory Corporation of America Holdings
  • 18. Mahesh Aqua Holdings (Pvt) Ltd.
  • 19. Mylab Discovery Solutions Pvt. Ltd.
  • 20. PT Riset Nusantara Genetika (Nusantics)
  • 21. Randox Laboratories Ltd.
  • 22. Reagen LLC
  • 23. Ring Biotechnology Co Ltd.
  • 24. Speedy Assay Sdn. Bhd.
  • 25. SUREBIO
  • 26. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. SHRIMP DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SHRIMP DISEASE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAY BASED KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RAPID TESTING KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EARLY MORTALITY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TAURA SYNDROME VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WHITE SPOT SYNDROME VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY YELLOW HEAD OR GILL ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE & MARINE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FISHERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023